CAHCARDINAL HEALTH INC

NYSE cardinalhealth.com


$ 98.90 $ -4.07 (-3.95 %)    

Friday, 03-May-2024 15:59:56 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 98.91
$ 101.31
$ 97.87 x 100
$ 98.93 x 100
$ 98.28 - $ 101.31
$ 75.98 - $ 115.52
3,446,183
na
24.23B
$ 0.77
$ 43.90
TBD
na
na ($ 0.02)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-02-2024 03-31-2024 10-Q
2 02-01-2024 12-31-2023 10-Q
3 11-03-2023 09-30-2023 10-Q
4 08-15-2023 06-30-2023 10-K
5 05-04-2023 03-31-2023 10-Q
6 02-02-2023 12-31-2022 10-Q
7 11-04-2022 09-30-2022 10-Q
8 08-11-2022 06-30-2022 10-K
9 05-05-2022 03-31-2022 10-Q
10 02-03-2022 12-31-2021 10-Q
11 11-09-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-K
13 05-06-2021 03-31-2021 10-Q
14 02-05-2021 12-31-2020 10-Q
15 11-05-2020 09-30-2020 10-Q
16 08-13-2020 06-30-2020 10-K
17 05-11-2020 03-31-2020 10-Q
18 02-06-2020 12-31-2019 10-Q
19 11-07-2019 09-30-2019 10-Q
20 08-20-2019 06-30-2019 10-K
21 05-09-2019 03-31-2019 10-Q
22 02-07-2019 12-31-2018 10-Q
23 11-08-2018 09-30-2018 10-Q
24 08-22-2018 06-30-2018 10-K
25 05-09-2018 03-31-2018 10-Q
26 02-08-2018 12-31-2017 10-Q
27 11-07-2017 09-30-2017 10-Q
28 08-10-2017 06-30-2017 10-K
29 05-02-2017 03-31-2017 10-Q
30 02-07-2017 12-31-2016 10-Q
31 11-02-2016 09-30-2016 10-Q
32 08-12-2016 06-30-2016 10-K
33 05-03-2016 03-31-2016 10-Q
34 02-02-2016 12-31-2015 10-Q
35 11-03-2015 09-30-2015 10-Q
36 08-13-2015 06-30-2015 10-K
37 05-05-2015 03-31-2015 10-Q
38 02-03-2015 12-31-2014 10-Q
39 11-05-2014 09-30-2014 10-Q
40 08-13-2014 06-30-2014 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evercore-isi-group-maintains-in-line-on-cardinal-health-raises-price-target-to-115

Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a In-Line and raises the price targe...

 baird-maintains-outperform-on-cardinal-health-lowers-price-target-to-128

Baird analyst Eric Coldwell maintains Cardinal Health (NYSE:CAH) with a Outperform and lowers the price target from $134 to ...

 cardinal-health-q3-2024-adj-eps-208-beats-195-estimate-sales-54911b-miss-56054b-estimate

Cardinal Health (NYSE:CAH) reported quarterly earnings of $2.08 per share which beat the analyst consensus estimate of $1.95 by...

 wells-fargo-maintains-underweight-on-cardinal-health-lowers-price-target-to-94

Wells Fargo analyst Stephen Baxter maintains Cardinal Health (NYSE:CAH) with a Underweight and lowers the price target from ...

 fda-says-cardinal-health-failure-to-ensure-syringes-in-convenience-kits-us-importing--distributing-have-510k-clearance-prevented-fda-from-checking-risks

- Reuters

 on-april-24-cardinal-health-got-warning-letter-from-fda

- Reuters

 stocks-set-to-snap-worst-losing-streak-in-nearly-2-years-gold-sinks-bitcoin-reclaims-66000-whats-driving-markets-monday

U.S. stocks are poised to break a six-day losing streak, marking the end of the longest downward trend since September 2022.

Core News & Articles

- Bloomberg

 drug-distributing-giant-cardinal-health-will-not-renew-optumrx-distribution-pact-stock-plunges

Discover the latest updates on Cardinal Health's nonrenewal of OptumRx contracts. Explore its fiscal 2024 guidance and long...

 cardinal-health-announced-that-its-pharmaceutical-distribution-contracts-with-optumrx-which-expire-at-the-end-of-june-2024-will-not-be-renewed

OptumRx is UnitedHealth's subsidiary 

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION